Effects of addition of fenofibrate in high risk patients with combined hyperlipidemia not controlled by pravastatin

被引：0
|
作者：
Ducobu, J.
Farnier, M.
Bryniarshi, L.
机构：
[1] CHU Tivoli, La Louviere, Belgium
[2] Point Med, Dijon, France
[3] Krakov, Pologne, Russia
来源：
DIABETES & METABOLISM | 2007年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S60 / S60
页数：1
相关论文
共 50 条
  • [31] Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia
    Milionis, HJ
    Papakostas, J
    Kakafika, A
    Chasiotis, G
    Seferiadis, K
    Elisaf, MS
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (08): : 825 - 830
  • [32] EFFECTS OF PRAVASTATIN (CS-514) ON BILIARY LIPID-METABOLISM IN PATIENTS WITH HYPERLIPIDEMIA
    HORIUCHI, I
    OHYA, T
    TAZUMA, S
    MIZUNO, T
    TAKIZAWA, I
    KAJIYAMA, G
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (03): : 226 - 230
  • [33] Effect of statins on LDL particle size in patients with familial combined hyperlipidemia: a comparison between atorvastatin and pravastatin
    Sirtori, CR
    Calabresi, L
    Pisciotta, L
    Cattin, L
    Pauciullo, P
    Montagnani, M
    Manzato, E
    Bon, GB
    Fellin, R
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2005, 15 (01) : 47 - 55
  • [34] Chylomicron remnants of various sizes are lowered more effectively by fenofibrate than by atorvastatin in patients with combined hyperlipidemia
    Westphal, S
    Wiens, L
    Güttler, K
    Dierkes, J
    Luley, C
    ATHEROSCLEROSIS, 2003, 171 (02) : 369 - 377
  • [35] Combination therapy with fluvastatin and fenofibrate in ischemic heart disease patients with combined hyperlipidemia and type 2 diabetes
    Sarano, NE
    Kozlov, SG
    Tvorogova, MG
    Lyakishev, AA
    Naumov, VG
    KARDIOLOGIYA, 2003, 43 (04) : 30 - 35
  • [36] Comparative metabolic effects of fenofibrate and atorvastatin in patients with combined hyperlipiderma
    Koh, KK
    Han, SH
    Quon, MJ
    Kang, WC
    Shin, MS
    Choi, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 396A - 396A
  • [37] EFFICACY AND SAFETY OF LONG-TERM COADMINISTRATION OF FENOFIBRATE AND EZETIMIBE IN PATIENTS WITH COMBINED HYPERLIPIDEMIA: RESULTS OF THE EFECTL TRIAL
    Oikawa, S.
    Yamashita, S.
    Nakaya, N.
    Sasaki, J.
    Kono, S.
    ATHEROSCLEROSIS, 2016, 252 : E230 - E230
  • [38] EFFECT OF PRAVASTATIN AND OMEGA-3-FATTY-ACIDS ON PLASMA-LIPIDS AND LIPOPROTEINS IN PATIENTS WITH COMBINED HYPERLIPIDEMIA
    CONTACOS, C
    BARTER, PJ
    SULLIVAN, DR
    ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (12): : 1755 - 1762
  • [39] Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia: relations with baseline lipid profiles
    Wang, TD
    Chen, WJ
    Lin, JW
    Cheng, CC
    Chen, MF
    Lee, YT
    ATHEROSCLEROSIS, 2003, 170 (02) : 315 - 323
  • [40] Efficacy and safety of a new hydroxymethylglutaryl-coenzyme a reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: Comparison with fenofibrate
    Ooi, TC
    Heinonen, T
    Alaupovic, P
    Davignon, J
    Leiter, L
    Lupien, PJ
    Sniderman, AD
    Tan, MH
    Tremblay, G
    Sorisky, A
    Shurzinske, L
    Black, DM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (09) : 1793 - 1799
12345